In line with this, our data clearly demonstrate that KCNJ3 expression is associated with ER positive breast cancer and that KCNJ3 levels correlate with ESR1 mRNA expression levels but not with expression levels of other estrogen receptors. Here, ESR1 is linked to breast carcinoma.